Skip to main content Skip to section navigation Skip to footer
Partnering Careers
IMV Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • DPX Delivery Platform
    • Overview
    • Scientific Materials
  • Pipeline
    • Overview
    • Maveropepimut-S
    • Expanded Access
  • News & Media
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contacts
    • FAQ
  • Contact
    • Get in Touch
    • Safety & Respect
  • CCAA Proceedings
  • Partnering
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Events
  • Email Alerts
Apr 05, 2010 4:49pm EDT

Immunovaccine Announces the Publication of DPX-0907 Preclinical Study

Mar 29, 2010 4:30pm EDT

Immunovaccine Begins Patient Recruitment for Phase 1 Trial of DPX-0907 Cancer Vaccine

Mar 02, 2010 8:40am EST

Immunovaccine Signs Licensing Deal with Pfizer Animal Health to Develop a Third Livestock Vaccine

Feb 23, 2010 8:30am EST

Immunovaccine Appoints James Hall as New Board Member

Feb 08, 2010 8:56am EST

Immunovaccine Presents Results for an Enhanced Anthrax Vaccine Candidate

Feb 04, 2010 8:45am EST

Immunovaccine Provides Corporate Update

Feb 02, 2010 6:00pm EST

Immunovaccine Hires Investor Relations Firm

Jan 28, 2010 6:00pm EST

Immunovaccine Grants Stock Options

Dec 09, 2009 8:45am EST

Immunovaccine Receives Clearance From FDA to Proceed With Phase 1 Clinical Trial for Its Therapeutic Cancer Vaccine

Nov 23, 2009 8:45am EST

Immunovaccine Licenses Vaccine Platform to Pfizer Animal Health

  • Previous Pagearrow_back
  • Page 1…
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Next Pagearrow_forward
rss_feed News RSS
  • Visit us on Twitter

    Twitter

  • Visit us on LinkedIn

    LinkedIn

  • Visit us on Youtube

    Youtube

© IMV Inc. All Rights Reserved.
Privacy Policy Terms of Use Sitemap Manage Cookie Preferences